Arterial blood pressure is the driving force for organ perfusion. Although hypotension is
common in acute care, there is a lack of accepted criteria for its definition. Most practitioners …

ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …

Synopsis: Captopril 1 is the first orally active inhibitor of angiotensin-converting enzyme to
become available. It has been studied to date primarily in hypertension. In mild to moderate …

ACE inhibitors effectively reduce systemic vascular resistance in patients with hypertension,
heart failure or chronic renal disease. This antihypertensive efficacy probably accounts for …

Thirty-three hypertensive patients with a wide range of renal function were studied during
initiation of angiotensin-converting enzyme inhibition with captopril to evaluate changes in …

Captopril is an orally active inhibitor of angiotensin-converting enzyme (ACE) and has been
widely studied in the treatment of patients with mild to moderate essential hypertension …

Angiotensin converting enzyme inhibitors represent a new class of agents which were
designed to retain only that unique property. Because of this inhibition, administration of …

During long-term captopril administration to hypertensive patients on maintenance
hemodialysis, a decrease in hemoglobin, hematocrit, and red blood cell count was observed …

Nifedipine (10 mg qid) and captopril (25 mg qid) were tested alone and in combination in 14
patients suffering from severe primary hypertension. Each study period was of 1 week's …

Systemic and regional hemodynamics and cardiac structural changes were studied in 12
patients with mild to moderately severe essential hypertension before and then 90 minutes …